Reply to Rodolfo Montironi, Liang Cheng, Marina Scarpelli, Alessia Cimadamore, Francesco Montorsi, and Antonio Lopez-Beltran's Letter to the Editor re: Gillian Vandekerkhove, Werner J. Struss, Matti Annala, et al. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer. Eur Urol 2019; 75:667-75: How Does Circulating DNA Reach the Blood Stream?

Wyatt Alexander W.; Chi Kim N.; Gleave Martin E.

首页> 外文期刊>European urology >Reply to Rodolfo Montironi, Liang Cheng, Marina Scarpelli, Alessia Cimadamore, Francesco Montorsi, and Antonio Lopez-Beltran's Letter to the Editor re: Gillian Vandekerkhove, Werner J. Struss, Matti Annala, et al. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer. Eur Urol 2019; 75:667-75: How Does Circulating DNA Reach the Blood Stream?

【24h】

Reply to Rodolfo Montironi, Liang Cheng, Marina Scarpelli, Alessia Cimadamore, Francesco Montorsi, and Antonio Lopez-Beltran's Letter to the Editor re: Gillian Vandekerkhove, Werner J. Struss, Matti Annala, et al. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer. Eur Urol 2019; 75:667-75: How Does Circulating DNA Reach the Blood Stream?

机译：回复Rodolfo Montironi，Liang Cheng，Marina Scarpelli，Alessia Cimadamore，Francesco Montorsi和Antonio Lopez-Beltran的信Re：Gillian Vandekerkhove，Werner J. Struss，Matti Annala，等。循环肿瘤DNA丰富和潜在效用于Novo转移性前列腺癌。 EUR UROL 2019; 75：667-75：循环DNA如何到达血液流？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European urology》 |2019年第3期|共2页
作者
Wyatt Alexander W.; Chi Kim N.; Gleave Martin E.;
展开▼
作者单位

Univ British Columbia Vancouver Prostate Ctr Dept Urol Sci 2660 Oak St Vancouver BC V6H 3Z6;

Univ British Columbia Vancouver Prostate Ctr Dept Urol Sci 2660 Oak St Vancouver BC V6H 3Z6;

Univ British Columbia Vancouver Prostate Ctr Dept Urol Sci 2660 Oak St Vancouver BC V6H 3Z6;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献

1. Reply to Rodolfo Montironi, Liang Cheng, Marina Scarpelli, Alessia Cimadamore, Francesco Montorsi, and Antonio Lopez-Beltran's Letter to the Editor re: Gillian Vandekerkhove, Werner J. Struss, Matti Annala, et al. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer. Eur Urol 2019; 75:667-75: How Does Circulating DNA Reach the Blood Stream? [J] . Wyatt Alexander W., Chi Kim N., Gleave Martin E. European urology . 2019,第3期

机译：回复Rodolfo Montironi，Liang Cheng，Marina Scarpelli，Alessia Cimadamore，Francesco Montorsi和Antonio Lopez-Beltran的信Re：Gillian Vandekerkhove，Werner J. Struss，Matti Annala，等。循环肿瘤DNA丰富和潜在效用于Novo转移性前列腺癌。 EUR UROL 2019; 75：667-75：循环DNA如何到达血液流？
2. Reply from authors re: Rodolfo Montironi, Antonio Lopez-Beltran, Liang Cheng, Francesco Montorsi, Marina Scarpelli. Central prostate pathology review: Should it be mandatory? Eur Urol 2013;64:199-201: Central pathology review: A must for prostate cancer studies and an option for selected patients in daily practise [J] . BottkeD., KristiansenG., GolzR., European urology . 2013,第2期

机译：作者的回复：Rodolfo Montironi，Antonio Lopez-Beltran，Liang Cheng，Francesco Montorsi，Marina Scarpelli。中央前列腺病理学检查：应该是强制性的吗？ Eur Urol 2013; 64：199-201：中央病理学审查：前列腺癌研究的必备条件，以及日常实践中某些患者的选择
3. Reply to Alessia Cimadamore, Marina Scarpelli, Liang Cheng, et al's Letter to the Editor, re: Maria Chiara Sighinolfi, Bernardo Rocco's Words of Wisdom re: EAU Guidelines: Prostate Cancer 2019. Mottet N, van den Bergh RCN, Briers E, et al. https://uroweb.org/guideline/prostate-Cancer/.Eur Urol 2019, 76:871 [J] . European urology . 2020,第5期

机译：回复哈伦西亚Cimadamore，Marina Scarpelli，Liang Cheng，等人的信，Re：Maria Chiara Sighinolfi，Bernardo Rocco的智慧之言：EAU指南：前列腺癌2019. Mottate N，Van Den Bergh RCN，Briers E，ET al。 https://uroweb.org/guideline/prostate-cancer/.eur Urol 2019,76：871
4. Reply to Francesco Piva Matteo Santoni Marina Scarpelli Alberto BrigantiAntonio Lopez-Beltran Liang Cheng Rossana Berardi Francesco Montorsi and RodolfoMontironi’s Letter to the editor re: Daniel M. Geynisman. Anti-programmed CellDeath Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response inPapillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features. Eur Urol2015;68:912-4 [O] . Tim N. Beck, Erica A. Golemis, Daniel M. Geynisman -1

机译：回覆Francesco PivaMatteo SantoniMarina ScarpelliAlberto Briganti安东尼奥·洛佩兹·贝尔特拉梁承罗萨娜·贝拉迪弗朗切斯科·蒙托西和罗多尔夫蒙蒂罗尼（Montironi）给编辑的信：丹尼尔·盖尼斯曼（Daniel M. Geynisman）。反编程单元死亡蛋白1（PD-1）抗体Nivolumab导致戏剧性和快速反应具有肉瘤样和横纹肌样特征的乳头状肾细胞癌。欧元乌罗尔2015; 68：912-4

著录项

相似文献

相关主题

期刊订阅